Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | (Q2)Feb 28, 2023 | (Q1)Nov 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 25.67%110.63B | 19.49%29.48B | 25.32%28.84B | 29.74%27.23B | 29.55%25.07B | 35.70%88.03B | 38.09%24.68B | 34.21%23.01B | 34.65%20.99B | 35.63%19.35B |
Cost of revenue | 29.58%75.27B | 23.19%19.83B | 29.53%19.69B | 35.10%18.47B | 31.72%17.27B | 32.70%58.09B | 29.69%16.1B | 31.92%15.2B | 33.08%13.67B | 37.12%13.11B |
Gross profit | 18.09%35.36B | 12.53%9.65B | 17.14%9.15B | 19.70%8.76B | 25.02%7.81B | 41.91%29.94B | 57.21%8.58B | 38.86%7.81B | 37.70%7.32B | 32.60%6.24B |
Operating expense | 35.07%24.82B | 17.77%6.18B | 45.36%6.77B | 45.68%5.89B | 35.05%5.99B | 29.55%18.38B | 37.41%5.25B | 11.57%4.66B | 17.47%4.04B | 60.96%4.44B |
Operating profit | -8.90%10.54B | 4.29%3.47B | -24.56%2.38B | -12.37%2.87B | 0.39%1.82B | 67.28%11.57B | 103.36%3.33B | 117.38%3.15B | 74.85%3.28B | -7.42%1.81B |
Net non-operating interest income (expenses) | -189.47%-55M | -157.14%-18M | -320.00%-21M | -200.00%-12M | -33.33%-4M | -35.71%-19M | -250.00%-7M | -25.00%-5M | 0.00%-4M | 25.00%-3M |
Non-operating interest income | --2M | --2M | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Non-operating interest expense | 200.00%57M | 185.71%20M | 320.00%21M | 200.00%12M | 33.33%4M | 35.71%19M | 250.00%7M | 25.00%5M | 0.00%4M | -25.00%3M |
Net investment income | -36.19%67M | -72.22%5M | -107.69%-2M | -25.81%23M | 36.67%41M | 0.00%105M | 5.88%18M | -13.33%26M | 10.71%31M | 0.00%30M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 40.23%-1.1B | 328.08%333M | -1,022.66%-1.44B | -1,258.09%-1.85B | -7.35%-146M | -128M | ||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | -581M | 0 | ||||||||
Less:Other special charges | ---24M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Less:Write off | --605M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Other non-operating income (expenses) | -51.71%169M | -120.00%-5M | 40.38%73M | -31.68%69M | -81.40%32M | -41.18%350M | -80.16%25M | -46.94%52M | -45.11%101M | -8.02%172M |
Income before tax | -11.04%9.03B | -0.40%3.21B | -67.99%992M | 61.50%2.95B | -6.18%1.88B | 36.10%10.15B | 96.46%3.22B | 97.14%3.1B | -12.25%1.83B | -7.38%2.01B |
Income tax | 3.25%3.79B | 45.82%1.34B | -47.85%655M | 30.86%1.02B | 8.04%766M | 55.71%3.67B | 175.75%921M | 160.58%1.26B | 2.23%781M | -8.52%709M |
Net income | -19.11%5.25B | -18.89%1.86B | -81.66%338M | 84.23%1.93B | -13.94%1.12B | 27.03%6.49B | 76.09%2.3B | 68.93%1.84B | -20.58%1.05B | -6.75%1.3B |
Net income continuous operations | -19.12%5.25B | -18.92%1.86B | -81.71%337M | 84.40%1.93B | -13.93%1.12B | 27.05%6.49B | 76.17%2.3B | 69.08%1.84B | -20.65%1.05B | -6.75%1.3B |
Noncontrolling interests | -50.63%118M | 0.00%31M | -57.14%21M | -52.13%45M | -67.69%21M | 82.44%239M | -32.61%31M | 28.95%49M | 168.57%94M | 441.67%65M |
Net income attributable to the company | -17.90%5.13B | -19.15%1.83B | -82.27%318M | 97.69%1.88B | -11.19%1.1B | 25.55%6.25B | 79.98%2.27B | 70.37%1.79B | -25.74%952M | -10.65%1.23B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -17.90%5.13B | -19.15%1.83B | -82.27%318M | 97.69%1.88B | -11.19%1.1B | 25.55%6.25B | 79.98%2.27B | 70.37%1.79B | -25.74%952M | -10.65%1.23B |
Gross dividend payment | ||||||||||
Basic earnings per share | -17.81%291.43 | -19.16%104.11 | -82.30%18.02 | 98.26%107 | -10.99%62.3 | 25.38%354.56 | 80.26%128.78 | 70.32%101.82 | -26.00%53.97 | -11.00%69.99 |
Diluted earnings per share | -17.76%291.17 | -19.09%104.04 | -82.27%18.02 | 98.27%106.87 | -10.96%62.23 | 25.66%354.03 | 80.26%128.58 | 70.46%101.66 | -25.87%53.9 | -10.47%69.89 |
Dividend per share | ||||||||||
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |